ERIKA LANCASTER: Open Payments
NPI 1053900936 · CULLMAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$604 in 31 payments from 16 companies in 2025. Trend: 2023 $90 · 2024 $813 · 2025 $604
Food & beverage: $604
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $149 |
| Indivior Inc. | 5 | $85 |
| Corcept Therapeutics | 3 | $59 |
| Lilly USA, LLC | 2 | $37 |
| ABBVIE INC. | 2 | $35 |
| Amgen Inc. | 2 | $34 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Exact Sciences Corporation | 1 | $23 |
| PFIZER INC. | 1 | $22 |
Products named: FARXIGA, SUBLOCADE, Korlym, MOUNJARO, VRAYLAR, OTEZLA, VERQUVO, Auvelity.
Industry payments across AL — which companies pay providers there.
